099430.KQ
Bio Plus Co., Ltd
KOE · Healthcare · Medical - Specialties · US
KRW 3,300.00
−0.90%Year over year
Reported trailing growth
- Revenue
- +11.2%
- EBITDA
- -24.5%
- EBIT
- -36.0%
- EPS
- -19.2%
- Free cash flow
- +91.3%
- Operating cash flow
- -34.3%
Forward estimates
Based on analyst estimates
- Revenue
- -33.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.0%
- EBITDA
- -7.3%
- EBIT
- -15.9%
- Net income
- -10.8%
- EPS
- -12.1%
- Free cash flow
- +61.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026